Ovid Therapeutics Inc (OVID)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,327 | 94,064 | 13,153 | 20,611 | 28,415 |
| Marketable Securities | 105,892 | 61,458 | 56,482 | 4,992 | 9,932 |
| Other current assets | 6,398 | 4,623 | 4,733 | 3,221 | 3,742 |
| TOTAL | $123,617 | $160,145 | $74,368 | $28,824 | $42,089 |
| Non-Current Assets | |||||
| PPE Net | 201 | 217 | 252 | 269 | 285 |
| Investments And Advances | 95,244 | 52,037 | 62,773 | 20,908 | 20,908 |
| Other Non-Current Assets | 12,911 | 13,229 | 13,541 | 13,847 | 14,146 |
| TOTAL | $108,356 | $65,483 | $76,566 | $35,024 | $35,339 |
| Total Assets | $231,973 | $225,628 | $150,934 | $63,848 | $77,428 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,072 | 8,876 | 1,956 | 1,710 | 3,950 |
| Accrued Expenses | 4,424 | 5,413 | 4,899 | 2,959 | 2,872 |
| TOTAL | $9,980 | $15,748 | $8,288 | $6,796 | $8,924 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | 718 | 718 |
| Other Non-Current Liabilities | 872 | 0 | 0 | 0 | 0 |
| TOTAL | $12,103 | $11,611 | $11,986 | $12,354 | $12,715 |
| Total Liabilities | $22,083 | $27,359 | $20,274 | $19,150 | $21,639 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 195,298 | 186,640 | 131,875 | 71,212 | 71,110 |
| Common Shares | 185 | 167 | 130 | 71 | 71 |
| Retained earnings | -353,710 | -338,701 | -321,713 | -331,376 | -319,218 |
| Other shareholders' equity | -750 | -422 | -202 | -126 | -69 |
| TOTAL | $209,890 | $198,269 | $130,660 | $44,698 | $55,789 |
| Total Liabilities And Equity | $231,973 | $225,628 | $150,934 | $63,848 | $77,428 |